Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 124.50 122.00 127.00 124.50 124.50 124.50 932 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 13.0 -23.1 -8.4 - 192

Amryt Pharma Share Discussion Threads

Showing 4976 to 4994 of 5375 messages
Chat Pages: Latest  203  202  201  200  199  198  197  196  195  194  193  192  Older
DateSubjectAuthorDiscuss
13/9/2019
16:27
Cheers Pap I wouldn't split hairs on a difference of 4,000,000 shares ! Lol its all pie in the sky until it happens ;) Enjoy the weather and weekend :)
richpassi
13/9/2019
15:25
Cathal Friel still has around 4,116,224 shares (via his Raglan Road vehicle) in AMYT (after taking into a/c the 1 for 6 consolidation. From the AMYT web site). He has hung onto them. At the moment they are worth around £5m to him. He'll also have 4,116,224 CVR's which could be worth up to another circa £5m to him in future IF all the milestones for AP101 are achieved. Not to be sniffed at, even for someone as rich as Cathal Friel.
papillon
13/9/2019
15:09
ali47fish - this morning I believe
bermudashorts
13/9/2019
15:00
Cathal says Nasdaq plan for November
alphabravo321
13/9/2019
14:55
when is this dated bermuda please no date with the video?
ali47fish
13/9/2019
14:14
Not sure whether this has already been posted but Cathal Friel gives his views on the Aegerion deal in the Proactive interview below:- Https://www.youtube.com/watch?v=ZqelBgsW39I
bermudashorts
13/9/2019
12:46
richpassi. Re my reply to you yesterday (post 4835). I made a very silly arithmetical error in the post. I stated that the maximum value of the CVR's (if AP101 passed all it's milestones) was £1.60 when it fact the RNS dated 27th August states CATEGORICALLY that the maximum pay out is US$1.48 (equivalent to £1.22 with an exchange rate of US$1 = £1.21) If one divides the maximum amount available to the CVR holders, US85m, by US$1.48 one gets the number of CVR's in existence by the cut off date of 20th September. That gives the number of CVR's as 57.432m NOT the 53.149m I have used in my post 4835. Apologies, richpassi, for my mistakes in post 4835. Hope you agree with my corrected figures. ATB
papillon
13/9/2019
11:06
Looks like you can sell above the mid price today, which is unusual for AMYT. Indicates demand for the shares?
papillon
13/9/2019
10:55
ali47fish. There is, as alphabravo states, a US$60m share placing @ 148p per share on the 24th September. If you buy AMYT shares before the cut off date of 20th September and keep them until after 20th September, as dim2602 states, you will be entitled to the CVR's. Whether the AMYT share price will drop after the 20th September, as dim2602 states, is open to question. That would normally be the case, but will it happen in this case bearing in mind that there is a £1.48 share placing just 4 days after and a fund manager like Mark Taub (see my post yesterday containing a link to his article) believes AMYT will be vastly undervalued compared with it's peer group on Nasdaq (AMYT intends to list on Nasdaq within 90 days of the Aegerion acquisition/RTO). Mark Taub was valuing AMYT (after it acquires Aegerion following the completion of the the RTO) almost solely on the circa US$136m sales revenue of the new AMYT, so how much value is being ascribed by investors to the CVR's (which could end up worthless) who can tell? Personally I believe dim2602 is correct and we could see a small, temporary, pull back in the share price after the 20th September, but it's by no means certain.
papillon
13/9/2019
08:56
Isn't there a 60 million capital raise on Sept 24th?
chica1
13/9/2019
08:06
If you buy AMYT shares before 20th Sept and keep them until after 20th Sept you will be on the register to receive the CVRs. Its much the same as a holding a share that goes ex-dividend on a certain day. You can buy this share the day before the XD date and sell it the day after and still receive the dividend. But its not necessarily free money because the market should assume that the current AMYT share price already includes the value of the CVR's. After 20th September this element is removed from the AMYT share, so the AMYT share price should fall in value. But this fall in value should be compensated by the fact that you would hold this value through your separate ownership of the CVR. My view is that the market probably doesn't know what value to apply to the CVR as its potential payout is subject to so many outcomes. I think the AMYT share price will fall only around 5p - 10p to reflect the ex CVR status and then quickly recover.
dlm2602
13/9/2019
07:05
Buys showing as sells
alphabravo321
13/9/2019
06:33
papillon what's happening on 24 sept?
ali47fish
12/9/2019
21:12
I see Bronxville has changed his tune!! LOL. He's definitely changed his mind on the debt that AMYT + Aegerion will have. Bronxville Posted in: AMYT Posts: 1,186 Price: 12.375 No Opinion RE: info please 22 May 2019 14:02 It could be American hedge funds dumping their worthless Aegerion bonds onto Amryt. You would hope Amryt management are smarter than that. Bronxville Posts: 1,185 Price: 106.00 No Opinion RE: The Prospects Tue 12:23 If it gets Nasdaq listing could be good.. Don't mind having debt on the books with 2 marketable drugs as financing is so cheap at the moment.. Bronxville Posts: 1,185 Price: 115.00 No Opinion Sept 24th Today 16:16 I wonder could this shoot ALOT higher than 1.48 prior Sept 24th. Shares are very tightly held so a technical bounce could be on the cards.
papillon
12/9/2019
20:49
Good point, waterloo. I made the same point back in May after the Aegerion deal was announced. papillon 30 May '19 - 09:29 - 4509 of 4849 "Also Socioderm were promised extra money (US$100m, or 50% of sale price whichever was the lesser) if a PRV was issued by the FDA and subsequently sold. AMYT shareholders will be getting NOTHING in return for a PRV being sold."
papillon
12/9/2019
17:58
the more i think about it in the absence of an ex date buying the shares now for the CVRs is taking a punt on getting on the register by 8pm on sept 20th, which is fairly unlikely so i reckon probably too late
richman777114
12/9/2019
17:48
Annoying thing about it though is IF Ap101 does get approval, it comes with a fast track. One recently sold for $95m (in years gone by have reached $300m in value). Still I guess the combined business gets the benefit, but would have been better to have had a % of that as part of the CVR.
waterloo01
12/9/2019
17:27
record date for the CVRs is 20th sept ie date one needs to be on register but no ex date given for dealing with, then without, the entitlement to the CVRsex date always some days prior to record date to allow for registrationsurely one cannot buy up to 20th and also be on the register as at the 20th?confusing
richman777114
12/9/2019
16:01
The value of the CVRs is made crystal clear in the RNS of the 27th, no need for any complex calculations: The value of these CVRs is up to US$1.48 per Ordinary Share (GBP1.22 based upon an exchange rate of GBP1:$1.21). The CVRs are payable in three tranches, being: -- A contingent entitlement of up to a maximum amount of $35,000,000 subject to the Food & Drug Administration ("FDA") issuing a Qualifying Approval in respect of AP101 prior to 1 July 2022; i.e. up to about 50p per share -- A contingent entitlement of up to a maximum amount of $15,000,000 subject to the European Medicines Agency ("EMA") issuing a Qualifying Approval in respect of AP101 prior to 1 July 2022; i.e. up to about 22p per share and -- A contingent entitlement of up to a maximum amount of $35,000,000 on Amryt achieving a 12-Month Trailing Net Product Revenue in excess of $75,000,000 from sales of AP101 prior to 30 June 2024. i.e. up to about 50p per share If none of the milestones are achieved, Scheme Shareholders and Option holders will not receive any additional consideration under the terms of the CVRs. In these circumstances, the value of each CVR would be zero. i.e. 0p per share Text in bold is mine.
webpax
Chat Pages: Latest  203  202  201  200  199  198  197  196  195  194  193  192  Older
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200127 09:23:47